Related Experiment Video
Updated: Apr 4, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Amantadine-Induced Livedo Racemosa
Paulo Ricardo Criado1, Afsaneh Alavi2, Neusa Yuriko Sakai Valente1
1São Paulo University, São Paulo, Brazil.
Amantadine can cause livedo racemosa, a skin condition presenting as a violaceous netlike pattern. This case report details two instances of livedo racemosa and leg edema linked to amantadine use, confirmed by biopsies showing vascular thrombi.
Area of Science:
- Dermatology
- Pharmacology
- Pathology
Background:
- Livedo reticularis is a recognized adverse effect of amantadine.
- Limited research exists on the association between amantadine and livedo reticularis.
- Livedo racemosa, distinct from livedo reticularis, presents with a violaceous, netlike skin pattern and unique histopathology.
Purpose of the Study:
- To report two cases of livedo racemosa and lower extremity edema following amantadine treatment.
- To highlight the clinical and histopathological findings in amantadine-induced livedo racemosa.
Main Methods:
- Case report of two patients treated with amantadine.
- Clinical examination and documentation of skin lesions and edema.
- Histopathological analysis of cutaneous biopsies.
Main Results:
- Both patients developed livedo racemosa and lower extremity edema after amantadine initiation.
- Cutaneous biopsies revealed intraluminal thrombi in subcutaneous blood vessels.
- No evidence of vasculitis was observed in the biopsies.
Conclusions:
- Amantadine may induce livedo racemosa, characterized by vascular thrombi without vasculitis.
- This finding expands the known dermatological adverse effects of amantadine.
- Further investigation into amantadine's vascular side effects is warranted.
More Related Videos
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Cholinergic Antagonists: Pharmacokinetics